Project introduction:

Guangzhou Calvoice Medical Technology Co., Ltd. focuses on the vertical blank field of speech feature analysis and intervention. It is a high-tech enterprise integrating R & D, production and sales formed in 2019 with seven doctoral and master's degree teams in six disciplines, including clinical medicine, artificial intelligence and integrated circuits. The main products of the company are clinical medical and preventive products (pathological voice screening robot, pathological voice diagnosis robot), chip module products (filter chip, acoustic frequency down chip), intelligent medical (pathological voice large database, remote diagnosis platform). Its main product pathological voice diagnosis robot is a comprehensive application of pathological voice intelligent neural network system, pathological voice big data, medical Internet of things, data fusion transmission and exchange, cloud computing, virtual cluster system and other technologies. It integrates pathological voice intelligent neural network with pathological screening diagnosis and rehabilitation through artificial intelligence. Based on the "distributed pathological voice big database", it adopts multiple artificial intelligence algorithm models to diagnose autism It is an original and multi-level product for early screening and clinical diagnosis of dysarthria, Alzheimer's disease, Parkinson's disease, language retardation and other diseases. To solve the problems of late discovery, difficult diagnosis, difficult identification and difficult rehabilitation, and fill the gaps at home and abroad. With the advantage of leading technology, the company has achieved rapid development. In 2019, the sales revenue was 11.1158 million yuan, and the export income was 450000 US dollars; In 2020, the sales revenue reached 50.1849 million yuan, and the R & D investment reached 5.4392 million yuan. The company's products are mainly used by hospitals, special education and rehabilitation institutions, nursing homes and communities, medical rehabilitation equipment manufacturers, industry partners and scientific research institutions. The company will continue to focus on the field of artificial intelligence + biomedicine, and quickly build the company into an internationally competitive leading enterprise in the segmented industry with speech feature extraction and analysis chips and artificial intelligence medical robot products as the core.